CATALAYER NEWS

FDA rejects Biohaven approval request for troriluzole, triggering R&D cost cutting - Fierce Biotech

Source: Fierce Biotech · 2025-11-05

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER

Related Topics

Biotech & FDA News

RELATED MARKETS

Prediction Markets

New Rihanna Album before GTA VI?52%New Playboi Carti Album before GTA VI?52%Will Jesus Christ return before GTA VI?48%

Open Catalayer terminal for live tracking →